Table 1 Susceptibility testing of Mycobacterium mucogenicum isolate
From: Mycobacterium mucogenicum bacteremia: major role of clinical microbiologists
Antimicrobial drugs | Minimal inhibitory concentration (mg/L) | Clinical breakpoints* (mg/L) |
|---|---|---|
amikacin | 2 | 16–64 |
tobramycin | 8 | 2–8 |
ciprofloxacin | 0.5 | 1–4 |
moxifloxacin | < 0.25 | 1–4 |
clarithromycin | 0.5 | 2–8 |
linezolid | 2 | 4–32 |
trimetoprim/sulfamethoxazole | < 0.25/4.75 | 2/38–4/76 |
cefoxitin | < 4 | 16–128 |
imipenem | < 2 | 4–32 |
doxycyclin | 0.25 | 1–8 |
minocyclin | < 1 | 1–8 |